Company news
Voyageur Pharmaceuticals Ltd (TSXV:VM) news
Voyageur Pharmaceuticals Ltd news releases on 6ix. Latest, Nov 1, 2022: The Power Play by The Market Herald Releases New Interviews with Tantalex, Rover…
Press releases — page 3
The Power Play by The Market Herald Releases New Interviews with Tantalex, Rover Metals, Gamelancer and Voyageur Discussing Their Latest News
November 1, 2022
Voyageur Pharmaceuticals Ltd. Designs Carbon Neutral Pharmaceutical Manufacturing Plant with a Carbon Credit De-Carbonization Strategy for Customers
October 31, 2022
The Power Play by The Market Herald Releases New Interviews with Else Nutrition, Silver Bullet Mines, Voyageur Pharmaceuticals, RevoluGROUP and Pelangio Discussing Their Latest News
October 24, 2022
Voyageur Pharmaceuticals Ltd. Signs an MOU for the Development of Carbon Fullerene Contrast Agents for Medical Imaging Applications and Related Carbon Capture Technology
October 24, 2022
Voyageur Pharmaceuticals Ltd. Submits Notice of Work to Extract 2,000 Tonnes of Barium Sulfate from Frances Creek Project
September 22, 2022
Voyageur Pharmaceuticals Ltd. Announces Resignation of CFO and Appointment of Interim CFO and Shares for Debt Transaction
August 15, 2022
Voyageur Pharmaceuticals Ltd. Announces Closing of Over Subscribed $1Million Private Placement and Issuance of Shares for Debt
June 16, 2022
Voyageur Pharmaceuticals Ltd. Announces Increase to Proposed Private Placement
May 31, 2022
Voyageur Pharmaceuticals Ltd. Announces Proposed Private Placement
May 26, 2022
Voyageur Pharmaceuticals Completes Milestone with the FDA and Continues to Move Towards Commercialization on Three Fronts
May 18, 2022
Voyageur Pharmaceuticals Ltd. Announces Issuance of Shares to Pay for Deposits and Debt
May 10, 2022
Voyageur Pharmaceuticals Announces Shareholder Update and Filing of Frances Creek Preliminary Economic Assessment Report
February 24, 2022
Voyageur Pharmaceuticals Announces Publication of the Jubilee Mountain NI 43-101 Report & Staking of Falcon Claims- Copper Polymetallic Assets
February 16, 2022
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' PEA with NPV of $344 million and 137% IRR for Frances Creek Pharmaceutical Barium Project in BC - Video Available on Investmentpitch.com
January 13, 2022
IIROC Trading Resumption - VM
January 11, 2022
Voyageur Pharmaceuticals Announces IRR of 137% and NPV of $344 Million from Preliminary Economic Assessment for the Frances Creek Pharmaceutical Barium Project
January 11, 2022
IIROC Trading Halt - VM
January 11, 2022
Voyageur Pharmaceuticals Provides Update on PEA Progress & Takes a Major Step Towards Production Start Up
December 6, 2021
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' MOU with Summit Nanotech to Develop Iodine Extraction Technology and Additions to Scientific Advisory Board - Video Available on Investmentpitch.com
November 9, 2021
Voyageur Pharmaceuticals & Summit Nanotech Corporation Sign Memorandum of Understanding for a Technology Development Project
November 8, 2021
Voyageur Pharmaceuticals Ltd., Announces The Completion of a New Scientific Advisory Board With World Class Leading Physicians
October 18, 2021
Voyageur Pharmaceuticals Ltd., Announces The Creation of a New Scientific Advisory Board With World Class Leading Physicians
September 14, 2021
Voyageur Pharmaceuticals Ltd. Announces Update To PEA and a Related New Opportunity To Market High Purity USP Barium Sulfate
August 19, 2021
Voyageur Pharmaceuticals Ltd. Announces Issuance of Stock Options and Deferred Share Units
August 12, 2021
Voyageur Pharmaceuticals Announces Board of Director Changes and 2nd quarter Financial Results
July 26, 2021
Voyageur Pharmaceuticals Ltd. Announces Completion of Private Placement
June 14, 2021
Voyageur Pharmaceuticals Ltd. Announces Closing of Second Tranche of Private Placement
May 28, 2021
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of 5th Product License for MultiXThick Radiographic Barium Contrast
May 17, 2021
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product Licenses for MultiXThin Radiographic Barium Contrast
May 5, 2021
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals and Beneficial Ruling by the D.C. Circuit Court of Appeals Qualifying Voyageurs Products as Devices not Drugs - Video Available on Investmentpitch.com
April 21, 2021
Recent Decision from DC Circuit Court Likely to Result in Less Cost and Faster Approvals for Voyageur Barium Products - Voyageur Hires Team of Experts to Support Product Roll-Out
April 20, 2021
Voyageur Pharmaceuticals Ltd. Announces up to $1,725,000 Private Placement Financing
April 13, 2021
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' Two New License Approvals from Health Canada for its MultiX Barium Sulfate Powder Covering Oral and Rectal Applications - Video Available on Investmentpitch.com
April 7, 2021
Voyageur Pharmaceuticals Ltd. Announces Two Health Canada Approvals and Issuance of Product Licenses for MultiX Ba; Radiographic Barium Contrast
April 5, 2021
Voyageur Pharmaceuticals Ltd. Announces Issuance of Stock Options
April 5, 2021
Voyageur Pharmaceuticals Ltd. Signs Manufacturing Agreement With Alberta Veterinarian Laboratories Ltd. for Barium Radiographic Contrast Production
March 23, 2021
Voyageur Pharmaceuticals Ltd. Receives $209,764.05 from Exercise of Warrants and Options
March 10, 2021
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals' Receipt of Approval from Health Canada for Two of the Company's Barium Contrast Products - Video Available on Investmentpitch.com
February 17, 2021
Voyageur Pharmaceuticals Ltd. Announces Second Health Canada Approval and Issuance of Product License for HDXBa; Radiographic Barium Contrast
February 16, 2021
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of Product License for SmoothX; Radiographic Barium Contrast Suspension
February 12, 2021
Voyageur Pharmaceuticals Ltd. Announces Second and Final Closing of Private Placement and Future Director Retirement
January 18, 2021
Voyageur Pharmaceuticals Ltd. Announces Increase to Private Placement and First Closing
December 31, 2020
Voyageur Files Further Updated NI 43-101 Report on the Frances Creek Barite Project
December 18, 2020
Voyageur Pharmaceuticals Ltd. Announces up to $600,000 Private Placement
December 9, 2020
Voyageur Pharmaceuticals Ltd. Announces Signing LOI for Contract Manufacturing of Barium Radiographic Contrast Media with Alberta Veterinarian Laboratories Ltd.
November 30, 2020
Voyageur Pharmaceuticals Ltd. Announces Withdrawal of Corporate Presentation and Update on the Fullerene Project
November 18, 2020
Voyageur Files Updated NI-43-101 Report on the Frances Creek Project & Completes SGS Canada Inc. Mine Site Visit for Advancement of PEA
November 2, 2020
Voyageur Signs Letter of Intent to Engage THINQ for Pharmaceutical Consulting, and Collaboration on Long Term Pharmaceutical Drug Development
July 27, 2020
Voyageur Announces Year-End Audited Financial Statements & MD&A
April 3, 2020
Voyageur Announces the Postponement of Filing Annual Financial Statements and MD&A due to COVID-19 related delays. Reschedules for April 3, 2020
March 27, 2020